CAS 2641646-59-3

Paridiprubart

CAS: 2641646-59-3

Reinheit: 95%

Molekulargewicht: G/Mol

Ref: IN-DA02AICN

Paridiprubart

CAS: 2641646-59-3

Paridiprubart (NI-0101) is a humanised monoclonal antibody targeting TLR4, ameliorative effects in COVID-19 patients with ARDS and rheumatoid arthritis.

Reinheit: 96.9% (SDS-PAGE); 98.5% (SEC-HPLC) - 96.9% (SDS-PAGE); 98.5% (SEC-HPLC)

Farbe und Form: Transparent Liquid

Molekulargewicht: 145.16 kDa (Predicted)

Ref: TM-T74427